The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair

OBJECTIVE: This study aims to explore the role of MARK2 in chemotherapeutic resistance and potential mechanism within cisplatin resistance models of CD133(+) MG-63 and MNNG/HOS cells. METHODS: CD133(−) and CD133(+) MG-63 and MNNG/HOS cells were differentiated and obtained by MACS(Magnetic bead sorti...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Bone Oncol
Asıl Yazarlar: Xu, Liang, Sun, Zhengkao, Wei, Xianfu, Tan, Hongdong, Kong, Peng, Li, Zhenfeng, Yang, Qiang, Dai, E'nuo, Li, Jianmin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7184251/
https://ncbi.nlm.nih.gov/pubmed/32368441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2020.100290
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller